{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T14:34:07Z","timestamp":1782398047330,"version":"3.54.5"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,30]],"date-time":"2018-11-30T00:00:00Z","timestamp":1543536000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12974-018-1375-2","type":"journal-article","created":{"date-parts":[[2018,11,30]],"date-time":"2018-11-30T11:50:10Z","timestamp":1543578610000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Counteracting neuroinflammation in experimental Parkinson\u2019s disease favors recovery of function: effects of Er-NPCs administration"],"prefix":"10.1186","volume":"15","author":[{"given":"Stephana","family":"Carelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toniella","family":"Giallongo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuzana","family":"Gombalova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Rey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Carlotta F.","family":"Gorio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Mazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Maria","family":"Di Giulio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,30]]},"reference":[{"issue":"1","key":"1375_CR1","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1002\/mds.25032","volume":"28","author":"EC Hirsch","year":"2013","unstructured":"Hirsch EC, Jenner P, Przedborski S. Pathogenesis of Parkinson\u2019s disease. Mov Disord. 2013;28(1):24\u201330.","journal-title":"Mov Disord"},{"issue":"4","key":"1375_CR2","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/S1474-4422(09)70062-6","volume":"8","author":"EC Hirsch","year":"2009","unstructured":"Hirsch EC, Hunot S. Neuroinflammation in Parkinson\u2019s disease: a target for neuroprotection? Lancet Neurol. 2009;8(4):382\u201397.","journal-title":"Lancet Neurol"},{"issue":"4","key":"1375_CR3","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1007\/s10495-008-0309-3","volume":"14","author":"OA Levy","year":"2009","unstructured":"Levy OA, Malagelada C, Greene LA. Cell death pathways in Parkinson\u2019s disease: proximal triggers, distal effectors, and final steps. Apoptosis: Int J Program Cell Death. 2009;14(4):478\u2013500.","journal-title":"Apoptosis: Int J Program Cell Death"},{"key":"1375_CR4","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13024-016-0094-3","volume":"11","author":"Y Zhou","year":"2016","unstructured":"Zhou Y, Lu M, Du RH, Qiao C, Jiang CY, Zhang KZ, Ding JH, Hu G. MicroRNA-7 targets Nod-like receptor protein 3 inflammasome to modulate neuroinflammation in the pathogenesis of Parkinson\u2019s disease. Mol Neurodegener. 2016;11:28.","journal-title":"Mol Neurodegener"},{"issue":"2","key":"1375_CR5","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.pathophys.2017.02.001","volume":"24","author":"B Kaur","year":"2017","unstructured":"Kaur B, Prakash A. Ceftriaxone attenuates glutamate-mediated neuro-inflammation and restores BDNF in MPTP model of Parkinson\u2019s disease in rats. Pathophysiology. 2017;24(2):71\u20139.","journal-title":"Pathophysiology"},{"issue":"1","key":"1375_CR6","first-page":"182","volume":"119","author":"V Brochard","year":"2009","unstructured":"Brochard V, Combadiere B, Prigent A, Laouar Y, Perrin A, Beray-Berthat V, Bonduelle O, Alvarez-Fischer D, Callebert J, Launay JM, Duyckaerts C, Flavell RA, Hirsch EC, Hunot S. Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease. J Clin Invest. 2009;119(1):182\u201392.","journal-title":"J Clin Invest"},{"issue":"2","key":"1375_CR7","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/0304-3940(94)90508-8","volume":"180","author":"M Mogi","year":"1994","unstructured":"Mogi M, Harada M, Kondo T, Riederer P, Inagaki H, Minami M, Nagatsu T. Interleukin-1 beta, interleukin-6, epidermal growth factor and transforming growth factor-alpha are elevated in the brain from parkinsonian patients. Neurosci Lett. 1994b;180(2):147\u201350.","journal-title":"Neurosci Lett"},{"issue":"1\u20132","key":"1375_CR8","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/0304-3940(94)90746-3","volume":"165","author":"M Mogi","year":"1994","unstructured":"Mogi M, Harada M, Riederer P, Narabayashi H, Fujita K, Nagatsu T. Tumor necrosis factor-alpha (TNF-alpha) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients. Neurosci Lett. 1994;165(1\u20132):208\u201310.","journal-title":"Neurosci Lett"},{"key":"1375_CR9","doi-asserted-by":"publisher","first-page":"S210","DOI":"10.1016\/S1353-8020(11)70065-7","volume":"1","author":"EC Hirsch","year":"2012","unstructured":"Hirsch EC, Vyas S, Hunot S. Neuroinflammation in Parkinson\u2019s disease. Parkinsonism Relat Disord. 2012;1:S210\u20132.","journal-title":"Parkinsonism Relat Disord"},{"issue":"3","key":"1375_CR10","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1007\/s12035-015-9103-8","volume":"53","author":"CJHM Klemann","year":"2016","unstructured":"Klemann CJHM, Martens GJM, Poelmans G, Visser JE. Validity of the MPTP-treated mouse as a model for Parkinson\u2019s disease. Mol Neurobiol. 2016;53(3):1625\u201336.","journal-title":"Mol Neurobiol"},{"issue":"3","key":"1375_CR11","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1007\/s12035-017-0496-4","volume":"55","author":"R Siracusa","year":"2018","unstructured":"Siracusa R, Paterniti I, Cordaro M, Crupi R, Bruschetta G, Campolo M, Cuzzocrea S, Esposito E. Neuroprotective effects of temsirolimus in animal models of Parkinson\u2019s disease. Mol Neurobiol. 2018;55(3):2403\u201319.","journal-title":"Mol Neurobiol"},{"issue":"10","key":"1375_CR12","doi-asserted-by":"publisher","first-page":"6145","DOI":"10.1073\/pnas.0937239100","volume":"100","author":"DC Wu","year":"2003","unstructured":"Wu DC, Teismann P, Tieu K, Vila M, Jackson-Lewis V, Ischiropoulos H, Przedborski S. NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson\u2019s disease. Proc Natl Acad Sci U S A. 2003;100(10):6145\u201350.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"1375_CR13","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/j.neuron.2013.09.004","volume":"79","author":"JT Bendor","year":"2013","unstructured":"Bendor JT, Logan TP, Edwards RH. The function of \u03b1-synuclein. Neuron. 2013;79(6):1044\u201366.","journal-title":"Neuron"},{"issue":"6","key":"1375_CR14","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1096\/fj.04-2751com","volume":"19","author":"W Zhang","year":"2005","unstructured":"Zhang W, Wang T, Pei Z, Miller DS, Wu X, Block ML, Wilson B, Zhang W, Zhou Y, Hong JS, Zhang J. Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson\u2019s disease. FASEB J. 2005;19(6):533\u201342.","journal-title":"FASEB J"},{"key":"1375_CR15","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1038\/sj.bjp.0707167","volume":"150","author":"PS Whitton","year":"2007","unstructured":"Whitton PS. Inflammation as a causative factor in the aetiology of Parkinson\u2019s disease. Br J Pharmacol. 2007;150:963\u201376.","journal-title":"Br J Pharmacol"},{"issue":"6","key":"1375_CR16","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1289\/ehp.1003013","volume":"119","author":"HM Gao","year":"2011","unstructured":"Gao HM, Zhang F, Zhou H, Kam W, Wilson B, Hong JS. Neuroinflammation and \u03b1-synuclein dysfunction potentiate each other, driving chronic progression of neurodegeneration in a mouse model of Parkinson\u2019s disease. Environ Health Perspect. 2011;119(6):807\u201314.","journal-title":"Environ Health Perspect"},{"issue":"1","key":"1375_CR17","doi-asserted-by":"publisher","first-page":"e55375","DOI":"10.1371\/journal.pone.0055375","volume":"8","author":"G Codolo","year":"2013","unstructured":"Codolo G, Plotegher N, Pozzobon T, Brucale M, Tessari I, Bubacco L, de Bernard M. Triggering of inflammasome by aggregated \u03b1-synuclein, an inflammatory response in synucleinopathies. PLoS One. 2013;8(1):e55375.","journal-title":"PLoS One"},{"issue":"2","key":"1375_CR18","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1042\/AN20120066","volume":"5","author":"V Sanchez-Guajardo","year":"2013","unstructured":"Sanchez-Guajardo V, Barnum CJ, Tansey MG, Romero-Ramos M. Neuroimmunological processes in Parkinson\u2019s disease and their relation to \u03b1-synuclein: microglia as the referee between neuronal processes and peripheral immunity. ASN Neuro. 2013;5(2):113\u201339.","journal-title":"ASN Neuro"},{"issue":"2","key":"1375_CR19","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.expneurol.2012.08.020","volume":"238","author":"C Depboylu","year":"2012","unstructured":"Depboylu C, Stricker S, Ghobril JP, Oertel WH, Priller J, H\u00f6glinger GU. Brain-resident microglia predominate over infiltrating myeloid cells in activation, phagocytosis and interaction with T-lymphocytes in the MPTP mouse model of Parkinson disease. Exp Neurol. 2012;238(2):183\u201391.","journal-title":"Exp Neurol"},{"key":"1375_CR20","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40035-015-0042-0","volume":"4","author":"Q Wang","year":"2015","unstructured":"Wang Q, Liu Y, Zhou J. Neuroinflammation in Parkinson\u2019s disease and its potential as therapeutic target. Transl Neurodeg. 2015;4:19.","journal-title":"Transl Neurodeg"},{"issue":"5","key":"1375_CR21","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s00281-013-0382-8","volume":"35","author":"VH Perry","year":"2013","unstructured":"Perry VH, Teeling J. Microglia and macrophages of the central nervous system: the contribution of microglia priming and systemic inflammation to chronic neurodegeneration. Semin Immunopathol. 2013;35(5):601\u201312.","journal-title":"Semin Immunopathol"},{"key":"1375_CR22","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1002\/ana.10566","volume":"53","author":"CW Olanow","year":"2003","unstructured":"Olanow CW, Schapira AHV, Agid Y. Neurodegeneration and prospects for neuroprotection and rescue in Parkinson\u2019s disease. Ann Neurol. 2003;53:S1.","journal-title":"Ann Neurol"},{"key":"1375_CR23","doi-asserted-by":"publisher","unstructured":"Lang AE, Espay AJ. Disease modification in Parkinson\u2019s disease: current approaches, challenges, and future considerations. Mov Disord. 2018;33(5):660\u2013677. \n                    https:\/\/doi.org\/10.1002\/mds.27360\n                    \n                  .","DOI":"10.1002\/mds.27360"},{"key":"1375_CR24","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.ejphar.2018.04.023","volume":"830","author":"AK Kakkar","year":"2018","unstructured":"Kakkar AK, Singh H, Medhi B. Old wines in new bottles: repurposing opportunities for Parkinson\u2019s disease. Eur J Pharmacol. 2018;830:115\u201327.","journal-title":"Eur J Pharmacol"},{"issue":"48","key":"1375_CR25","doi-asserted-by":"publisher","first-page":"12497","DOI":"10.1523\/JNEUROSCI.3719-06.2006","volume":"26","author":"T Yasuhara","year":"2006","unstructured":"Yasuhara T, Matsukawa N, Hara K, Yu G, Xu L, Maki M, Kim SU, Borlongan CV. Transplantation of human neural stem cells exerts neuroprotection in a rat model of Parkinson\u2019s disease. J Neurosci. 2006;26(48):12497\u2013511.","journal-title":"J Neurosci"},{"issue":"5","key":"1375_CR26","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/nrn1908","volume":"7","author":"G Martino","year":"2006","unstructured":"Martino G, Pluchino S. The therapeutic potential of neural stem cells. Nat Rev Neurosci. 2006;7(5):395\u2013406.","journal-title":"Nat Rev Neurosci"},{"issue":"29","key":"1375_CR27","doi-asserted-by":"publisher","first-page":"12175","DOI":"10.1073\/pnas.0704091104","volume":"104","author":"DE Redmond Jr","year":"2007","unstructured":"Redmond DE Jr, Bjugstad KB, Teng YD, Ourednik V, Ourednik J, Wakeman DR, Parsons XH, Gonzalez R, Blanchard BC, Kim SU, Gu Z, Lipton SA, Markakis EA, Roth RH, Elsworth JD, Sladek JR Jr, Sidman RL, Snyder EY. Behavioral improvement in a primate Parkinson\u2019s model is associated with multiple homeostatic effects of human neural stem cells. Proc Natl Acad Sci U S A. 2007;104(29):12175\u201380.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1375_CR28","doi-asserted-by":"publisher","first-page":"634","DOI":"10.2119\/2008-00077.Bottai","volume":"14","author":"D Bottai","year":"2008","unstructured":"Bottai D, Madaschi L, Di Giulio AM, Gorio A. Viability-dependent promoting action of adult neural precursors in spinal cord injury. Mol Med. 2008;14:634\u201344.","journal-title":"Mol Med"},{"key":"1375_CR29","first-page":"703e719","volume":"24","author":"S Carelli","year":"2015","unstructured":"Carelli S, Giallongo T, Marfia G, Merli D, Ottobrini L, Degrassi A, Basso MD, Di Giulio AM, Gorio A. Exogenous adult post mortem neural precursors attenuate secondary degeneration, and promote myelin sparing and functional recovery following experimental spinal cord injury. Cell Transpl. 2015;24:703e719.","journal-title":"Cell Transpl"},{"key":"1375_CR30","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.neuropharm.2017.03.035","volume":"119","author":"S Carelli","year":"2017","unstructured":"Carelli S, Giallongo T, Viaggi C, Latorre E, Gombalova Z, Raspa A, Mazza M, Vaglini F, Di Giulio AM, Gorio A. Recovery from experimental parkinsonism by intrastriatal application of erythropoietin or EPO-releasing neural precursors. Neuropharmacology. 2017;119:76\u201390.","journal-title":"Neuropharmacology"},{"issue":"6","key":"1375_CR31","first-page":"583","volume":"35","author":"S Carelli","year":"2017","unstructured":"Carelli S, Giallongo T, Gombalova Z, Merli D, Di Giulio AM, Gorio A. EPO-releasing neural precursor cells promote axonal regeneration and recovery of function in spinal cord traumatic injury. Restor Neurol Neurosci. 2017;35(6):583\u201399.","journal-title":"Restor Neurol Neurosci"},{"key":"1375_CR32","first-page":"8(5)","volume":"27","author":"S Carelli","year":"2016","unstructured":"Carelli S, Giallongo T, Viaggi C, Gombalova Z, Latorre E, Mazza M, Vaglini F, Di Giulio AM, Gorio A. Grafted neural precursors integrate into mouse striatum, differentiate and promote recovery of function through release of erythropoietin in MPTP-treated mice. ASN Neuro. 2016;27:8(5).","journal-title":"ASN Neuro"},{"key":"1375_CR33","unstructured":"Carelli S, Giallongo T, Latorre E, Caremoli F, Gerace C, Basso MD, Di Giulio AM, Goria A. 2014. Adult mouse post mortem neural precursors survive, differentiate, counteract cytokine production and promote functional recovery after transplantation in experimental traumatic spinal cord injury. J Stem Cell Res Transpl 2014;1:1008."},{"key":"1375_CR34","doi-asserted-by":"publisher","first-page":"86e98","DOI":"10.1016\/j.nbd.2011.02.004","volume":"43","author":"G Marfia","year":"2011","unstructured":"Marfia G, Madaschi L, Marra F, Menarini M, Bottai D, Formenti A, Bellardita C, Di Giulio AM, Carelli S, Gorio A. Adult neural precursors isolated from post mortem brain yield mostly neurons: an erythropoietin-dependent process. Neurobiol Dis. 2011;43:86e98.","journal-title":"Neurobiol Dis"},{"key":"1375_CR35","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1182\/blood-2005-10-4066","volume":"107","author":"F Verdier","year":"2006","unstructured":"Verdier F, Gomez S, Lacombe C, Mayeux P. Selected anti-Epo receptor antibodies predict Epo receptor expression. Blood. 2006;107:1892\u20135.","journal-title":"Blood"},{"key":"1375_CR36","doi-asserted-by":"publisher","first-page":"189e204","DOI":"10.1093\/brain\/awp290","volume":"133","author":"YF Cui","year":"2010","unstructured":"Cui YF, Hargus G, Xu JC, Schmid JS, Shen YQ, Glatzel M, Schachner M, Bernreuther C. Embryonic stem cell-derived L1 overexpressing neural aggregates enhance recovery in Parkinsonian mice. Brain. 2010;133:189e204.","journal-title":"Brain"},{"key":"1375_CR37","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S0165-0270(02)00360-6","volume":"123","author":"JL Tillerson","year":"2003","unstructured":"Tillerson JL, Miller GW. Grid performance test to measure behavioral impairment in the MPTP-treated-mouse model of Parkinsonism. J Neurosci Methods. 2003;123:189\u2013200.","journal-title":"J Neurosci Methods"},{"key":"1375_CR38","unstructured":"Kim ST, Son HJ, Choi JH, Ji IJ, Hwang O. (2010). Vertical grid test and modified horizontal grid test are sensitive methods for evaluating motor dysfunctions in the MPTP mouse model of Parkinson\u2019s disease. Brain Res 2010;1306:176\u2013183."},{"key":"1375_CR39","volume-title":"The mouse brain in stereotaxic coordinates, second ed","author":"G Paxinos","year":"2001","unstructured":"Paxinos G, Franklin KBJ. The mouse brain in stereotaxic coordinates, second ed. Hong Kong: Academic Press; 2001."},{"key":"1375_CR40","first-page":"378e381","volume":"296","author":"EC Jensen","year":"2013","unstructured":"Jensen EC. Quantitative analysis of histological staining and fluorescence using ImageJ. Anat Rec. 2013;296:378e381.","journal-title":"Anat Rec"},{"issue":"724","key":"1375_CR41","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.ejphar.2013.05.035","volume":"5","author":"R Newton","year":"2014","unstructured":"Newton R. Anti-inflammatory glucocorticoids: changing concepts. Eur J Pharmacol. 2014;5(724):231\u20136.","journal-title":"Eur J Pharmacol"},{"key":"1375_CR42","first-page":"29e35","volume":"609","author":"Y JunKonishi","year":"1993","unstructured":"JunKonishi Y, Chui DH, Hirose H, Kunishita T, Tabira T. Trophic effect of erythropoietin and other hematopoietic factors on central cholinergic neurons in vitro and in vivo. Brain Res. 1993;609:29e35 Pharmacol. 2014 Feb 5;724:231\u20136. doi: 10.1016\/j.ejphar.2013.05.035. Epub 2013.","journal-title":"Brain Res"},{"key":"1375_CR43","doi-asserted-by":"publisher","first-page":"3233e3242","DOI":"10.1242\/jeb.01049","volume":"207","author":"HH Marti","year":"2004","unstructured":"Marti HH. Erythropoietin and the hypoxic brain. J Exp Biol. 2004;207:3233e3242.","journal-title":"J Exp Biol"},{"key":"1375_CR44","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3389\/fncel.2013.00053","volume":"7","author":"MC Leal","year":"2013","unstructured":"Leal MC, Casabona JC, Puntel M, Pitossi FJ. Interleukin-1\u03b2 and tumor necrosis factor-\u03b1: reliable targets for protective therapies in Parkinson\u2019s disease? Front Cell Neurosci. 2013;7:53.","journal-title":"Front Cell Neurosci"},{"key":"1375_CR45","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.neuroscience.2014.11.018","volume":"302","author":"MS Moehle","year":"2015","unstructured":"Moehle MS, West AB. M1 and M2 immune activation in Parkinson\u2019s disease: foe and ally. Neuroscience. 2015;302:59\u201373.","journal-title":"Neuroscience"},{"key":"1375_CR46","doi-asserted-by":"publisher","first-page":"815e1822","DOI":"10.1182\/blood-2004-04-1559","volume":"105","author":"S Aggarwal","year":"2005","unstructured":"Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood. 2005;105:815e1822.","journal-title":"Blood"},{"key":"1375_CR47","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1002\/glia.22474","volume":"61","author":"S Fumagalli","year":"2013","unstructured":"Fumagalli S, Perego C, Ortolano F, De Simoni MG. CX3CR1 deficiency induces an early protective inflammatory environment in ischemic mice. Glia. 2013;61:827\u201342.","journal-title":"Glia"},{"key":"1375_CR48","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.nbd.2016.09.017","volume":"96","author":"C Perego","year":"2016","unstructured":"Perego C, Fumagalli S, Zanier ER, Carlino E, Panini N, Erba E, De Simoni MG. Macrophages are essential for maintaining a M2 protective response early after ischemic brain injury. Neurobiol Dis. 2016;96:284\u201393.","journal-title":"Neurobiol Dis"},{"key":"1375_CR49","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s00429-009-0231-7","volume":"214","author":"CE Ribak","year":"2009","unstructured":"Ribak CE, Shapiro LA, Perez ZD, Spigelman I. Microglia associated granule cell death in the normal adult dentate gyrus. Brain Struct Funct. 2009;214:25\u201335.","journal-title":"Brain Struct Funct"},{"issue":"12","key":"1375_CR50","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1038\/70978","volume":"5","author":"GT Liberatore","year":"1999","unstructured":"Liberatore GT, Jackson-Lewis V, Vukosavic S, Mandir AS, Vila M, McAuliffe WG, Dawson VL, Dawson TM, Przedborski S. Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease. Nat Med. 1999;5(12):1403\u20139.","journal-title":"Nat Med"},{"issue":"7","key":"1375_CR51","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1093\/jnen\/59.7.628","volume":"59","author":"YP Wu","year":"2000","unstructured":"Wu YP, Matsuda J, Kubota A, Suzuki K, Suzuki K. Infiltration of hematogenous lineage cells into the demyelinating central nervous system of twitcher mice. J Neuropathol Exp Neurol. 2000;59(7):628\u201339.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"7","key":"1375_CR52","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/nn1715","volume":"9","author":"AE Cardona","year":"2006","unstructured":"Cardona AE, Pioro EP, Sasse ME, Kostenko V, Cardona SM, Dijkstra IM, Huang D, Kidd G, Dombrowski S, Dutta R, Lee JC, Cook DN, Jung S, Lira SA, Littman DR, Ransohoff RM. Control of microglial neurotoxicity by the fractalkine receptor. Nat Neurosci. 2006;9(7):917\u201324.","journal-title":"Nat Neurosci"},{"issue":"11","key":"1375_CR53","doi-asserted-by":"publisher","first-page":"e80908","DOI":"10.1371\/journal.pone.0080908","volume":"8","author":"MH Barros","year":"2013","unstructured":"Barros MH, Hauck F, Dreyer JH, Kempkes B, Niedobitek G. Macrophage polarisation: an immunohistochemical approach for identifying M1 and M2 macrophages. PLoS One. 2013;8(11):e80908.","journal-title":"PLoS One"},{"issue":"8","key":"1375_CR54","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.it.2008.05.002","volume":"29","author":"HM Gao","year":"2008","unstructured":"Gao HM, Hong JS. Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression. Trends Immunol. 2008;29(8):357\u201365.","journal-title":"Trends Immunol"},{"key":"1375_CR55","first-page":"9","volume":"10","author":"AJ McFarland","year":"2016","unstructured":"McFarland AJ, Davey AK, Anoopkumar-Dukie S. Phorbol 12-myristate 13-acetate (PMA)-differentiated THP-1 monocytes as a validated microglial-like model in vitro. World Academy of Science, Engineering and Technology International Journal of Pharmacological and Pharmaceutical. Sciences. 2016;10:9.","journal-title":"Sciences"},{"key":"1375_CR56","doi-asserted-by":"publisher","first-page":"179ps7","DOI":"10.1126\/scitranslmed.3005568","volume":"5","author":"MA Fischbach","year":"2013","unstructured":"Fischbach MA, Bluestone JA, Lim WA. Cell-based therapeutics: the next pillar of medicine. Sci Transl Med. 2013;5:179ps7.","journal-title":"Sci Transl Med"},{"key":"1375_CR57","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1742-2094-5-8","volume":"5","author":"JB Koprich","year":"2008","unstructured":"Koprich JB, Reske-Nielsen C, Mithal P, Isacson O. Neuroinflammation mediated by IL-1beta increases susceptibility of dopamine neurons to degeneration in an animal model of Parkinson\u2019s disease. J Neuroinflammation. 2008;5:8.","journal-title":"J Neuroinflammation"},{"issue":"8","key":"1375_CR58","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1038\/nn.4338","volume":"19","author":"RM Ransohoff","year":"2016","unstructured":"Ransohoff RM. A polarizing question: do M1 and M2 microglia exist? Nat Neurosci. 2016;19(8):987\u201391.","journal-title":"Nat Neurosci"},{"key":"1375_CR59","doi-asserted-by":"publisher","first-page":"523","DOI":"10.3389\/fimmu.2014.00523","volume":"5","author":"WS Bond","year":"2014","unstructured":"Bond WS, Rex TS. Evidence that erythropoietin modulates neuroinflammation through differential action on neurons, astrocytes, and microglia. Front Immunol. 2014;5:523.","journal-title":"Front Immunol"},{"issue":"14","key":"1375_CR60","doi-asserted-by":"publisher","first-page":"9450","DOI":"10.1073\/pnas.142287899","volume":"99","author":"A Gorio","year":"2002","unstructured":"Gorio A, Gokmen N, Erbayraktar S, Yilmaz O, Madaschi L, Cichetti C, Di Giulio AM, Vardar E, Cerami A, Brines M. Recombinant human erythropoietin counteracts secondary injury and markedly enhances neurological recovery from experimental spinal cord trauma. ProcNatlAcadSciU S A. 2002;99(14):9450\u20135.","journal-title":"ProcNatlAcadSciU S A"},{"key":"1375_CR61","doi-asserted-by":"publisher","first-page":"177e182","DOI":"10.1016\/j.neulet.2007.08.022","volume":"425","author":"G Chen","year":"2007","unstructured":"Chen G, Shi JX, Hang CH, Xie W, Liu J, Liu X. Inhibitory effect on cerebral inflammatory agents that accompany traumatic brain injury in a rat model: a potential neuroprotective mechanism of recombinant human erythropoietin (rhEPO). Neurosci Lett. 2007;425:177e182.","journal-title":"Neurosci Lett"},{"key":"1375_CR62","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1096\/fj.03-0203fje","volume":"13","author":"HM Gao","year":"2003","unstructured":"Gao HM, Liu B, Zhang W, Hong JS. Synergistic dopaminergic neurotoxicity of MPTP and inflammogen lipopolysaccharide: relevance to the etiology of Parkinson\u2019 disease. Official Publication of the FASEB J. 2003;13:1957\u20139.","journal-title":"Official Publication of the FASEB J"},{"issue":"Suppl 1","key":"1375_CR63","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1007\/s10654-011-9581-6","volume":"26","author":"K Wirdefeldt","year":"2011","unstructured":"Wirdefeldt K, Adami HO, Cole P, Trichopoulos D, Mandel J. Epidemiology and etiology of Parkinson\u2019s disease: a review of the evidence. Eur J Epidemiol. 2011;26(Suppl 1):S1\u2013S58.","journal-title":"Eur J Epidemiol"},{"key":"1375_CR64","doi-asserted-by":"publisher","first-page":"C1","DOI":"10.1152\/ajpcell.1992.263.1.C1","volume":"263","author":"EN Benveniste","year":"1992","unstructured":"Benveniste EN. Inflammatory cytokines within the central nervous system: sources, function, and mechanism of action. Am J Physiol. 1992;263:C1\u201316.","journal-title":"Am J Physiol"},{"key":"1375_CR65","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/S0167-5699(99)01573-X","volume":"21","author":"JD Sedgwick","year":"2000","unstructured":"Sedgwick JD, Riminton DS, Cyster JG, Korner H. Tumor necrosis factor: a master-regulator of leukocyte movement. Immunol Today. 2000;21:110\u20133.","journal-title":"Immunol Today"},{"key":"1375_CR66","first-page":"1127e1132","volume":"35","author":"ML Block","year":"2007","unstructured":"Block ML, Hong JS. Chronic microglial activation and progressive dopaminergic neurotoxicity. Biochem Trans. 2007;35:1127e1132.","journal-title":"Biochem Trans"},{"key":"1375_CR67","doi-asserted-by":"publisher","first-page":"1285e1291","DOI":"10.1212\/WNL.38.8.1285","volume":"38","author":"PL McGeer","year":"1988","unstructured":"McGeer PL, Itagaki S, Boyes BE, McGeer EG. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson\u2019s and Alzheimer\u2019s disease brains. Neurology. 1988;38:1285e1291.","journal-title":"Neurology"},{"key":"1375_CR68","unstructured":"Sofroniew MV. (2005). Reactive astrocytes in neural repair and protection. Neuroscientist 2005;11:400\u2013407."},{"issue":"3","key":"1375_CR69","doi-asserted-by":"publisher","first-page":"e90942","DOI":"10.1371\/journal.pone.0090942","volume":"9","author":"Y Liu","year":"2014","unstructured":"Liu Y, Luo B, Han F, Li X, Xiong J, Jiang M, Yang X, Wu Y, Zhang Z. Erythropoietin-derived nonerythropoietic peptide ameliorates experimental autoimmune neuritis by inflammation suppression and tissue protection. PLoS One. 2014;9(3):e90942.","journal-title":"PLoS One"},{"key":"1375_CR70","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/nrn3053","volume":"12","author":"S David","year":"2011","unstructured":"David S, Kroner A. Repertoire of microglial and macrophage responses after spinal cord injury. Nat Rev Neurosci. 2011;12:388\u201399.","journal-title":"Nat Rev Neurosci"},{"issue":"3","key":"1375_CR71","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s13311-014-0277-y","volume":"11","author":"ER Zanier","year":"2014","unstructured":"Zanier ER, Pischiutta F, Riganti L, Marchesi F, Turola E, Fumagalli S, Perego C, Parotto E, Vinci P, Veglianese P, D\u2019Amico G, Verderio C, De Simoni MG. Bone marrow mesenchymal stromal cells drive protective M2 microglia polarization after brain trauma. Neurotherapeutics. 2014;11(3):679\u201395.","journal-title":"Neurotherapeutics"},{"issue":"6","key":"1375_CR72","doi-asserted-by":"publisher","first-page":"484e494","DOI":"10.1038\/nrn1687","volume":"6","author":"M Brines","year":"2005","unstructured":"Brines M, Cerami A. Emerging biological roles for erythropoietin in the nervous system. Nat Rev Neurosci. 2005;6(6):484e494.","journal-title":"Nat Rev Neurosci"},{"key":"1375_CR73","first-page":"9733e9743","volume":"21","author":"T Shingo","year":"2000","unstructured":"Shingo T, Sorokan ST, Shimazaki T, Weiss S. Erythropoietin regulates the in vitro and in vivo production of neuronal progenitors by mammalian forebrain neural stem cells. J Neurosci. 2000;21:9733e9743.","journal-title":"J Neurosci"},{"issue":"2","key":"1375_CR74","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1111\/gbb.12001","volume":"12","author":"A Dhanushkodi","year":"2013","unstructured":"Dhanushkodi A, Akano EO, Roguski EE, Xue Y, Rao SK, Matta SG, Rex TS, MP MD. A single intramuscular injection of rAAV-mediated mutant erythropoietin protects against MPTP-induced parkinsonism. Genes Brain Behav. 2013;12(2):224\u201333.","journal-title":"Genes Brain Behav"},{"key":"1375_CR75","doi-asserted-by":"publisher","first-page":"55e70","DOI":"10.1016\/j.brainres.2013.01.042","volume":"1502","author":"J Thomas Tayra","year":"2013","unstructured":"Thomas Tayra J, Kameda M, Yasuhara T, Agari T, Kadota T, Wang F, Kikuchi Y, Liang H, Shinko A, Wakamori T, Vcelar B, Weik R, Date I. The neuroprotective and neurorescue effects of carbamylated erythropoietin Fc fusion protein (CEPO-Fc) in a rat model of Parkinson\u2019s disease. Brain Res. 2013;1502:55e70.","journal-title":"Brain Res"},{"key":"1375_CR76","doi-asserted-by":"publisher","first-page":"1e5","DOI":"10.1016\/j.npep.2014.10.003","volume":"49","author":"O Erbas","year":"2015","unstructured":"Erbas O, \u00c7\u0131nar BP, Solmaz V, \u00c7avu\u015fo\u011flu T, Ates U. The neuroprotective effect of erythropoietin on experimental Parkinson model in rats. Neuropeptides. 2015;49:1e5.","journal-title":"Neuropeptides"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-018-1375-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12974-018-1375-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-018-1375-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,16]],"date-time":"2019-12-16T10:06:17Z","timestamp":1576490777000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-018-1375-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,30]]},"references-count":76,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1375"],"URL":"https:\/\/doi.org\/10.1186\/s12974-018-1375-2","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,30]]},"assertion":[{"value":"12 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal experiments in this study have been approved by the Institutional Animal Care and Use Committee of Milan University, in accordance with the European Communities Directive of September 2010 (2010\/63\/UE) for the Care and Use of Laboratory Animals.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable (no human data or tissues were used in this paper).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All the contributing authors have seen and approved the manuscript. All authors declare that they have no competing interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"333"}}